IOX1 activity as sepsis therapy and an antibiotic against multidrug-resistant bacteria
Abstract Sepsis is caused by organ dysfunction initiated by an unrestrained host immune response to infection. The emergence of antibiotic-resistant bacteria has rapidly increased in the last decades and has stimulated a firm research platform to combat infections caused by antibiotic-resistant bact...
Guardado en:
Autores principales: | Su Jin Lee, Jueng Soo You, Amal Gharbi, Yong Joo Kim, Mi Suk Lee, Dong Hwan Kim, Keun Woo Lee, In Duk Jung, Yeong Min Park |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f2408c62fcc84bdaaaea1ace308d3416 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
IOX1 impedes host inflammation in imiquimod-triggered psoriasis
por: Joo Eun Shin, et al.
Publicado: (2021) -
Romo1-Derived Antimicrobial Peptide Is a New Antimicrobial Agent against Multidrug-Resistant Bacteria in a Murine Model of Sepsis
por: Hye-Ra Lee, et al.
Publicado: (2020) -
Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria
por: Naqvi SZ, et al.
Publicado: (2013) -
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria
por: Alysha G. Elliott, et al.
Publicado: (2020) -
Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapy
por: Jing Liu, et al.
Publicado: (2021)